Dunad Therapeutics

Dunad

This biopharmaceutical company develops orally bioavailable small-molecule protein degradation therapies for patients with oncology and central nervous system disorders.

Kesmalea Therapeutics

This drug discovery company develops oral, central nervous system penetrant protein degraders to treat oncology and neurological diseases.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

Ribonaut Therapeutics

Ribonaut Therapeutics develops small molecule drugs that target and degrade disease-causing RNA to treat neurological conditions and movement disorders for human patients.

Cyclera Therapeutics

This company develops catalytic protein degradation therapeutics to treat neuropsychiatric, neurodegenerative and cancer disorders for patients with central nervous system diseases.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Arvinas

This biopharmaceutical company develops protein degradation therapies to treat patients with cancer and neurodegenerative diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.